Regulation of Muscle Mass by Follistatin and Activins
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Myostatin is a TGF-β family member that normally acts to limit skeletal muscle mass. Follistatin is a myostatin-binding protein that can inhibit myostatin activity in vitro and promote muscle growth in vivo. Mice homozygous for a mutation in the Fst gene have been shown to die immediately after birth but have a reduced amount of muscle tissue, consistent with a role for follistatin in regulating myogenesis. Here, we show that Fst mutant mice exhibit haploinsufficiency, with muscles of Fst heterozygotes having significantly reduced size, a shift toward more oxidative fiber types, an impairment of muscle remodeling in response to cardiotoxin-induced injury, and a reduction in tetanic force production yet a maintenance of specific force. We show that the effect of heterozygous loss of Fst is at least partially retained in a Mstn-null background, implying that follistatin normally acts to inhibit other TGF-β family members in addition to myostatin to regulate muscle size. Finally, we present genetic evidence suggesting that activin A may be one of the ligands that is regulated by follistatin and that functions with myostatin to limit muscle mass. These findings potentially have important implications with respect to the development of therapeutics targeting this signaling pathway to preserve muscle mass and prevent muscle atrophy in a variety of inherited and acquired forms of muscle degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We and others have previously demonstrated that growth differentiation factor-8 (GDF8; also known as myostatin) and activin A (ActA) are the two major ligands mediating the muscle-minimization actions of ActRIIA/B receptors22,26–30.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The function of MSTN in muscle is at least partially redundant with that of another TGF-β family member, activin A (13–16).”
From Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight (2020) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FST acts as an inhibitor of members of the TGF-β superfamily, including myostatin and activins [185,186], and can function as a promoter of skeletal muscle growth [187].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [187]
In the citing paper
“Both follistatin and GASPs inhibit the activities of GDF11 and myostatin; accordingly, follistatin (Fst)-heterozygous47 and Gasp1-null or Gasp2-null48 mice have smaller muscles and increased GDF11 and myostatin bioactivity.”
From The central role of muscle stem cells in regenerative failure with aging (2015) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Self-citationRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 3×
“Follistatin is a potent myostatin inhibitor that can cause dramatic increases in muscle mass when overexpressed as a transgene in mice (18, 21, 22).”
BackgroundSelf-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Self-citationClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice carrying the targeted allele were crossed to EIIa-cre transgenic mice (33) to generate mice in which recombination had occurred between the outside LoxP sites (denoted by triangles), thereby resulting in a mutant allele in which exons 3–5 were completely deleted in the germline.”
MethodInduction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907
Self-citationThe regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831
Self-citationMosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Self-citationMyostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily
Chang, H., Brown, C. W., & Matzuk, M. M. (2002) · Endocrine Reviews · doi:10.1210/er.2002-0003 · Cited by 787
Self-citationContractile properties of skeletal muscles from young, adult and aged mice.
Brooks, S. V., & Faulkner, J. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017279 · Cited by 777
Multiple defects and perinatal death in mice deficient in follistatin
Matzuk, M. M., Lu, N., Vogel, H., Sellheyer, K., Roop, D. R., & Bradley, A. (1995) · Nature · doi:10.1038/374360a0 · Cited by 584
Self-citationFunctional analysis of activins during mammalian development
Matzuk, M. M., Kumar, T. R., Vassalli, A., Bickenbach, J. R., Roop, D. R., Jaenisch, R., & Bradley, A. (1995) · Nature · doi:10.1038/374354a0 · Cited by 578
Self-citationRebbapragada, A., Benchabane, H., Wrana, J. L., Celeste, A. J., & Attisano, L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7230-7242.2003 · Cited by 565
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
Whittemore, L.-A., Song, K., Li, X., Aghajanian, J., Davies, M., Girgenrath, S., Hill, J. J., Jalenak, M., Kelley, P., Knight, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02953-4 · Cited by 503
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
Lee, S.-J., Reed, L. A., Davies, M. V., Girgenrath, S., Goad, M. E. P., Tomkinson, K. N., Wright, J. F., Barker, C., Ehrmantraut, G., Holmstrom, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505996102 · Cited by 501 · cited 2×
“(ACVR2B) had been shown to cause increases in muscle mass not only in wild-type mice but also in Mstn / mice, implying that these inhibitors were exerting their effects by targeting other TGF- family members in addition to myostatin (7, 18, 21).”
BackgroundSelf-citationMcPherron, A. C., Lawler, A. M., & Lee, S.-J. (1999) · Nature Genetics · doi:10.1038/10320 · Cited by 471 · cited 1×
“Initial gene-knockout studies demonstrated that mice completely lacking GDF-11 exhibit multiple developmental defects and die during the perinatal period (51), which precluded a detailed analysis of the role of GDF-11 in muscle.”
BackgroundSelf-citationGrobet, L., Poncelet, D., Royo, L. J., Brouwers, B., Pirottin, D., Michaux, C., Ménissier, F., Zanotti, M., Dunner, S., & Georges, M. (1998) · Mammalian Genome · doi:10.1007/s003359900727 · Cited by 471
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases
Wolfman, N. M., McPherron, A. C., Pappano, W. N., Davies, M. V., Song, K., Tomkinson, K. N., Wright, J. F., Zhao, L., Sebald, S. M., Greenspan, D. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534946100 · Cited by 454
Self-citationHill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 443 · cited 2×
“Previous studies had shown that like follistatin, FSTL-3 (follistatinlike 3; also called FLRG) is capable of blocking myostatin activity in vitro (31) and promoting muscle growth when overexpressed in vivo (21, 22).”
BackgroundLack of myostatin results in excessive muscle growth but impaired force generation
Amthor, H., Macharia, R., Navarrete, R., Schuelke, M., Brown, S. C., Otto, A., Voit, T., Muntoni, F., Vrbóva, G., Partridge, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604893104 · Cited by 425
Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis
Amthor, H., Nicholas, G., McKinnell, I., Kemp, C. F., Sharma, M., Kambadur, R., & Patel, K. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.01.046 · Cited by 401
Vassalli, A., Matzuk, M. M., Gardner, H. A., Lee, K. F., & Jaenisch, R. (1994) · Genes & Development · doi:10.1101/gad.8.4.414 · Cited by 398
Self-citationQuadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways
Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316
Self-citationRelationships between Transforming Growth Factor-β1, Myostatin, and Decorin
Zhu, J., Li, Y., Shen, W., Qiao, C., Ambrosio, F., Lavasani, M., Nozaki, M., Branca, M. F., & Huard, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704146200 · Cited by 269
Haidet, A. M., Rizo, L., Handy, C., Umapathi, P., Eagle, A., Shilling, C., Boue, D., Martin, P. T., Sahenk, Z., Mendell, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709144105 · Cited by 267
Gilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2009 · Cited by 248 · cited 2×
“Moreover, a recent study showed that activin A is capable of inducing atrophy when overexpressed in muscle (40).”
BackgroundSelf-citationThe biology of activin: recent advances in structure, regulation and function
Xia, Y., & Schneyer, A. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0549 · Cited by 232
Girgenrath, S., Song, K., & Whittemore, L.-A. (2005) · Muscle & Nerve · doi:10.1002/mus.20175 · Cited by 228
Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice
McCroskery, S., Thomas, M., Platt, L., Hennebry, A., Nishimura, T., McLeay, L., Sharma, M., & Kambadur, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02482 · Cited by 214
Inhibins, activins and follistatin in reproduction
de Kretser, D. M. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.529 · Cited by 211
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194
Tsuchida, K., Arai, K. Y., Kuramoto, Y., Yamakawa, N., Hasegawa, Y., & Sugino, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006114200 · Cited by 192
Self-citationMuscle regeneration in the prolonged absence of myostatin
Wagner, K. R., Liu, X., Chang, X., & Allen, R. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408729102 · Cited by 187
Modulating skeletal muscle mass by postnatal, muscle‐specific inactivation of the myostatin gene
Grobet, L., Pirottin, D., Farnir, F., Poncelet, D., Royo, L. J., Brouwers, B., Christians, E., Desmecht, D., Coignoul, F., Kahn, R., et al. (2003) · genesis · doi:10.1002/gene.10188 · Cited by 180
Gamer, L. W., Wolfman, N. M., Celeste, A. J., Hattersley, G., Hewick, R., & Rosen, V. (1999) · Developmental Biology · doi:10.1006/dbio.1998.9191 · Cited by 170 · cited 1×
“An obvious candidate was GDF-11, which is highly related to myostatin (1, 50).”
BackgroundRedundancy of myostatin and growth/differentiation factor 11 function
McPherron, A. C., Huynh, T. V., & Lee, S.-J. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-24 · Cited by 165
Self-citationFSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults
Mukherjee, A., Sidis, Y., Mahan, A., Raher, M. J., Xia, Y., Rosen, E. D., Bloch, K. D., Thomas, M. K., & Schneyer, A. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607966104 · Cited by 157
Souza, T. A., Chen, X., Guo, Y., Sava, P., Zhang, J., Hill, J. J., Yaworsky, P. J., & Qiu, Y. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0290 · Cited by 142
Cadena, S. M., Tomkinson, K. N., Monnell, T. E., Spaits, M. S., Kumar, R., Underwood, K. W., Pearsall, R. S., & Lachey, J. L. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00866.2009 · Cited by 134
Pituitary actions of ligands of the TGF-β family: activins and inhibins
Bilezikjian, L. M., Blount, A. L., Donaldson, C. J., & Vale, W. W. (2006) · Reproduction · doi:10.1530/rep.1.01073 · Cited by 127
Systemic administration of L ‐arginine benefits mdx skeletal muscle function
Barton, E. R., Morris, L. D., Kawana, M., Bish, L. T., & Toursel, T. (2005) · Muscle & Nerve · doi:10.1002/mus.20425 · Cited by 124
Self-citationActivin βC and βE Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration
Lau, A. L., Kumar, T. R., Nishimori, K., Bonadio, J., & Matzuk, M. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6127-6137.2000 · Cited by 124
Self-citationMuscle growth after postdevelopmental myostatin gene knockout
Welle, S., Bhatt, K., Pinkert, C. A., Tawil, R., & Thornton, C. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00531.2006 · Cited by 113 · cited 1×
“In this respect, selective postnatal loss of myostatin signaling as a result of either deletion of the Mstn gene (2, 3) or pharmacological inhibition of myostatin activity (4–7) can cause significant muscle fiber hypertrophy, demonstrating that myostatin plays an important role in regulating muscle homeostasis in adul…”
BackgroundTargeting myostatin for therapies against muscle-wasting disorders.
Tsuchida, K. (2008) · PubMed · Cited by 84
Self-citationMice homozygous for a null mutation of activin βB are viable and fertile
Schrewe, H., Gendron‐Maguire, M., Harbison, M. L., & Gridley, T. (1994) · Mechanisms of Development · doi:10.1016/0925-4773(94)90094-9 · Cited by 83
TENOVER, J. S., MCLACHLAN, R. I., DAHL, K. D., BURGER, H. G., KRETSER, D. M. D., & BREMNER, W. J. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-455 · Cited by 82
Baccarelli, A., Morpurgo, P. S., Corsi, A. M., Vaghi, I., Fanelli, M., Cremonesi, G., Vaninetti, S., Beck‐Peccoz, P., & Spada, A. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00117-6 · Cited by 79
Schneyer, A., Schoen, A., Quigg, A., & Sidis, Y. (2003) · Endocrinology · doi:10.1210/en.2002-0203 · Cited by 71
Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice
Morine, K. J., Bish, L. T., Pendrak, K., Sleeper, M. M., Barton, E. R., & Sweeney, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009176 · Cited by 64
Self-citationOpposing Effects of Activin A and Follistatin on Developing Skeletal Muscle Cells
Link, B. A., & Nishi, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3575 · Cited by 56
Influence of age and sex on serum concentrations of total dimeric activin A
Loria, P., Petraglia, F., Concari, M., Bertolotti, M., Martella, P., Luisi, S., Grisolia, C., Foresta, C., Volpe, A., Genazzani, A., et al. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390487 · Cited by 54
During hematopoiesis, expression of FLRG, a novel activin A ligand, is regulated by TGF-β
Maguer‐Satta, V., Bartholin, L., Jeanpierre, S., Gadoux, M., Bertrand, S., Martel, S., Magaud, J. ‐., & Rimokh, R. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(00)00675-5 · Cited by 48
Reproductive hormones: ageing and the perimenopause
Robertson, D. M., & Burger, H. (2002) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810706.x · Cited by 39
Inhibins, Activins, and Follistatin in the Aging Female and Male
Hurwitz, J. M., & Santoro, N. (2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-831896 · Cited by 39
Activin A inhibits formation of skeletal muscle during chick development
He, L., Vichev, K., Macharia, R., Huang, R., Christ, B., Patel, K., & Amthor, H. (2005) · Anatomy and Embryology · doi:10.1007/s00429-005-0454-1 · Cited by 31
Schiaffino, S., & Salviati, G. (1997) · Methods in cell biology · doi:10.1016/s0091-679x(08)60387-8 · Cited by 24 · cited 1×
“Fiber typing was performed with antibodies recognizing myosin heavy chain (MHC)2a (SC-71), MHC 2b (BF-F3), and MHC 1 (BAF-8) as previously described (64).”
MethodMacNaughton, J. A., Bangah, M., McCloudt, P. I., & Burger, H. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03546.x · Cited by 21
Serum levels of inhibin B in men of different age groups
Bohring, C., & Krause, W. K. H. (2003) · The Aging Male · doi:10.1080/tam.6.2.73.78 · Cited by 17
Cited by
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Schiaffino, S., & Mammucari, C. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-4 · Cited by 816
“In adult skeletal muscle, muscle hypertrophy can be induced and muscle wasting prevented by blocking myostatin either via postdevelopmental myostatin gene knockout, or with follistatin (a myostatin antagonist) or anti-myostatin antibodies or a soluble ActRIIB decoy receptor (see [19,20] and references therein).”
BackgroundGDF11 increases with age and inhibits skeletal muscle regeneration
Egerman, M. A., Cadena, S. M., Gilbert, J. A., Meyer, A., Nelson, H. N., Swalley, S. E., Mallozzi, C., Jacobi, C., Jennings, L. L., Clay, I., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.010 · Cited by 527
“, 2009), resulted in an even greater increase in muscle size (Lee et al., 2010).”
The central role of muscle stem cells in regenerative failure with aging
Blau, H. M., Cosgrove, B. D., & Ho, A. T. V. (2015) · Nature Medicine · doi:10.1038/nm.3918 · Cited by 437
Mechanisms for fiber-type specificity of skeletal muscle atrophy
Wang, Y., & Pessin, J. E. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328360272d · Cited by 414
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414
“This is demonstrated by the comparison between the wasted Fst+/ mouse and the normal muscle mass of mice expressing only the Fst288 isoform (Lee et al., 2010; Brown et al., 2011).”
Background
Metadata
- Authors
- Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R.
- Affiliations
- Johns Hopkins University (US)
- University of Miami (US)
- Baylor College of Medicine (US)
- Fujita Health University (JP)
- University of Pennsylvania (US)
- ORCID
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-10-01
- Volume
- 24
- Issue
- 10
- Pages
- 1998-2008
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC2954636
- OpenAlex
- W2029816532
- Semantic Scholar
- 50765d8f8086769e58ab3497a6b5260266268e0b
- Cited by
- 273
- References
- 64
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 16 · 2018: 13 · 2017: 13 · 2016: 22 · 2015: 21 · 2014: 18 · 2013: 21 · 2012: 22
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (1dp2od004515-01)
- National Institute on Aging (R01AG037193)
- National Cancer Institute (R01CA122596)
- National Institute of General Medical Sciences (R01GM092758)
- National Institute of Neurological Disorders and Stroke (K08NS055879)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR052646, R01AR060636, R01AR059685)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD032067)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- follistatin, myostatin, activin A, TGF-beta superfamily, skeletal muscle mass, muscle fiber type shift, muscle remodeling, tetanic force, muscle atrophy, muscle degeneration, muscle growth
- MeSH terms
- Animals, Humans, Mice, Inbred C57BL, Muscle Contraction, Organ Size, Mice, Knockout, Muscle, Skeletal, Muscle Development, Activins, Follistatin, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.